genetics Archives

In the Lab By Megan Molteni

3 CRISPR editing innovations to watch in 2022

First Opinion By Victor DiRita and Stefano Bertuzzi

Gain-of-function research advances knowledge and saves lives

Special Report By Eric Boodman

How medicine erased Black women from a ‘white man’s disease’

Health By Isabella Cueto

Q&A: After finding few answers about her own rare cancer, Corrie Painter is crowdsourcing to fill cancer ‘data vacuum’

Biotech By Megan Molteni

‘Growing a chair is easy’ and other words of wisdom from the audacious George Church

First Opinion By Christopher J. Wells

Personalized medicine goes far beyond genetics

Health By Andrew Joseph

Sequencing whole genomes helps diagnose far more rare diseases, study shows

Biotech By Adam Feuerstein

Centessa drug shows early promise for inherited lung disease, but liver safety issue seen in small study

Health By Megan Molteni

Public-private partnership launched to accelerate gene therapies for rare diseases

Biotech By Megan Molteni

Eight years after a landmark Supreme Court ruling on DNA ownership, its ramifications are becoming clearer

Health Tech By Katie Palmer and Casey Ross

3 pressing questions on 23andMe’s pivot into primary care

In the Lab By Megan Molteni

New CRISPR tools could fix diseases caused by large DNA rearrangements, scientists report

Pharmalot By Ed Silverman

Citing competitive concerns, European Commission seeks to intervene in Illumina’s $8 billion acquisition of Grail

Biotech By Matthew Herper and Damian Garde

STAT+ Conversation: What’s next in gene therapy

Biotech By Matthew Herper and Megan Molteni

Return of the mammoth? George Church-backed company launches with $15 million for elephant-sized quest

Biotech By Kate Sheridan

In another sign of RNA’s growing popularity, the cancer startup Replicate is relaunching

In the Lab By Theresa Gaffney

Never-smokers’ lung cancers are genetically different from smokers’ tumors, study shows

Health By Andrew Joseph

Can parents handle finding out their newborn is at higher risk of certain diseases? A small study suggests they can

In the Lab By Megan Molteni

A new technology, based on a quirk of evolutionary biology, may be the next big thing for CRISPR

In the Lab By Megan Molteni

Discovery of rare mutation in a brain protein adds fuel to debate over cause of Alzheimer’s disease

Pharmalot By Ed Silverman

As Bluebird backpedals from Europe, small gene and cell therapy players face tough hurdles

Biotech By Damian Garde

Virtual Event: Gene therapy’s next steps

In the Lab By Megan Molteni

Scientists plumbing mysterious RNAs in the human genome find a possible treatment for an inherited disorder

Health By Claudia López Lloreda

Large study finds genetic signals that might be used to predict early menopause

Health Tech By Anissa Gardizy — Boston Globe

Most Read

Mutations tied to blood cancers and other diseases may surprisingly protect against Alzheimer’s

Last-gasp gene therapy saved a Syrian refugee’s life. Five years later, the boy is thriving and a clinical trial is starting

Virus expert Trevor Bedford on annual Covid boosters and the inevitable next pandemic

Here’s who might replace Francis Collins as NIH director

Lab tests show risks of using CRISPR gene editing on embryos

Human reproductive cloning: The curious incident of the dog in the night-time

23andMe had devastating news about my health. I wish a person had delivered it

Our child received a devastating diagnosis before she was born. We decided to protect her

All Coverage

3 CRISPR editing innovations to watch in 2022

Gain-of-function research advances knowledge and saves lives

How medicine erased Black women from a ‘white man’s disease’

Q&A: After finding few answers about her own rare cancer, Corrie Painter is crowdsourcing to fill cancer ‘data vacuum’

‘Growing a chair is easy’ and other words of wisdom from the audacious George Church

Personalized medicine goes far beyond genetics

Sequencing whole genomes helps diagnose far more rare diseases, study shows

Centessa drug shows early promise for inherited lung disease, but liver safety issue seen in small study

Public-private partnership launched to accelerate gene therapies for rare diseases

Eight years after a landmark Supreme Court ruling on DNA ownership, its ramifications are becoming clearer

3 pressing questions on 23andMe’s pivot into primary care

New CRISPR tools could fix diseases caused by large DNA rearrangements, scientists report

Citing competitive concerns, European Commission seeks to intervene in Illumina’s $8 billion acquisition of Grail

STAT+ Conversation: What’s next in gene therapy

Return of the mammoth? George Church-backed company launches with $15 million for elephant-sized quest

In another sign of RNA’s growing popularity, the cancer startup Replicate is relaunching

Never-smokers’ lung cancers are genetically different from smokers’ tumors, study shows

Can parents handle finding out their newborn is at higher risk of certain diseases? A small study suggests they can

A new technology, based on a quirk of evolutionary biology, may be the next big thing for CRISPR

Discovery of rare mutation in a brain protein adds fuel to debate over cause of Alzheimer’s disease

As Bluebird backpedals from Europe, small gene and cell therapy players face tough hurdles

Virtual Event: Gene therapy’s next steps

Scientists plumbing mysterious RNAs in the human genome find a possible treatment for an inherited disorder

Large study finds genetic signals that might be used to predict early menopause

Deep Genomics raises $180 million to automate drug discovery